Hims & Hers Enters Testosterone Market: Stock Surges

Hims & Hers stock jumps as the telehealth giant dives into testosterone replacement therapy, offering personalized treatments and a needle-free oral option. Is this a game-changer for the company's growth in men's health, or just another volatile swing for this unpredictable stock? Plus, a revenue forecast boost adds to the investor buzz. Hosted on Acast. See acast.com/privacy for more information.